Le Lézard
Classified in: Ebola virus, Health
Subject: ACC

New Number of Shares and Votes in Karo Pharma


STOCKHOLM, Oct. 31, 2019 /PRNewswire/ -- As previously announced, Karo Pharma Aktiebolag ("Karo Pharma") has completed a rights issue of 60,700,422 shares, with the purpose of repaying a part of the financing of Karo Pharma's acquisition of Trimb Holding AB as well as to strengthen Karo Pharma's financial capacity to carry out acquisitions of companies and product portfolios. As a result of the rights issue, the number of shares and votes in Karo Pharma has increased during the month of October.

Prior to the rights issue, the number of shares and votes in Karo Pharma amounted to 164,332,782. 60,556,339 new shares subscribed for by virtue of subscription rights and 144,083 new shares subscribed for without subscription rights have been registered with the Swedish Companies Registration Office (Sw. Bolagsverket) during October. Hence, as of today, 31 October 2019, the last trading day of the month, the number of shares and votes in Karo Pharma amounts to 225,033,204.

For further information, please contact:

Christoffer Lorenzen, CEO, +4673-501-7620, [email protected]

Jon Johnsson, CFO, +4673-507-8861, [email protected]

About Karo Pharma

Karo Pharma is a pharmaceutical company specialised in sales and marketing of prescription pharmaceuticals and over-the-counter products sold in pharmacies and retail. Karo Pharma is listed on Nasdaq Stockholm Mid Cap.

This information is such information that Karo Pharma is obliged to make public pursuant to the Swedish Financial Instruments Trading Act (Sw. lag (1991:980) om handel med finansiella instrument). The information was submitted for publication, through the agency of the contact persons set out above, at 17:00 CEST on 31 October 2019.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/karo-pharma/r/new-number-of-shares-and-votes-in-karo-pharma,c2949698

The following files are available for download:

https://mb.cision.com/Main/72/2949698/1132759.pdf

Press release (PDF)


These press releases may also interest you

21 mar 2019
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...



News published on and distributed by: